In a report released today, Stephen Willey from Stifel Nicolaus maintained a Buy rating on Geron (GERN – Research Report), with a price target ...

Fintel reports that on December 6, 2024, BMO Capital initiated coverage of IGM Biosciences (NasdaqGS:IGMS) with a Outperform ...

BMO Capital initiated coverage of IGM Biosciences (IGMS) with an Outperform rating and $21 price target IGM is a clinical-stage biotechnology ...

IGM Biosciences has pivoted from cancer therapeutics to autoimmune diseases despite setbacks, showing a 25% stock increase since last October. Click for more on IGMS.

Quest Partners LLC lessened its stake in IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) by 86.2% in the 3rd quarter, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A new paper published in Science from the MacAskill lab in NPP, led by graduate student Karyna Mishchanchuk, shows that a part of the brain called the hippocampus is really important for a key ...

Metrion Biosciences (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Lee Patterson as its ...

Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women's health, today announces a $10.4 million strategic investment from the Bill & Melinda Gates ...

A webcast of the fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/. About Harmony Biosciences Harmony ...